Drug Profile
Anti-TGF beta monoclonal antibody - Eli Lilly and Company
Alternative Names: Anti-TGF-beta-1 monoclonal antibody for diabetes - Eli Lilly and CompanyLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Class Monoclonal antibodies; Neuroprotectants
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 31 Dec 2010 Phase-II clinical trials in Diabetes mellitus in USA (SC)